Barely Significant
← all excerpts

Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control.

Diabetes Care · 2011 · PMC3142059 · PMID 21715517

Europe PMCDOI
1
hedged sentence
0.0508
closest p · 1.0× alpha
0.0508
boldest claim

The sentences

a strong trendP = 0.0508so close (0.05 < p ≤ 0.1)
RASS results ( 13 ) were consistent with those of ∼5 years DIRECT-Prevent 1 ( 14 ) where there was a strong trend ( P = 0.0508) for a reduction in the primary end point, time to two-steps or more DR progression, in type 1 diabetic patients with no DR at baseline who were randomized to candesartan.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.